Prognostic and biological significance of survivin expression in patients with diffuse large B-cell lymphoma treated with rituximab-CHOP therapy
Zhiyu Liu(Tongji University), Ken H. Young(Duke Medical Center), Ruifang Sun(Union Hospital), Michael Møller(Hospital South West Jutland), Karen Dybkær(Aalborg University Hospital), Govind Bhagat(Columbia University Irving Medical Center), Benjamin M. Parsons(Gundersen Health System), Maurilio Ponzoni(San Raffaele University of Rome), Eric D. Hsi(Mayo Clinic), J. Han van Krieken(Radboud University Nijmegen), Zijun Y. Xu‐Monette(Duke University), Attilio Orazi(Texas Tech University), Alexandar Tzankov(University of Basel), Carlo Visco(University of Verona), Xin Cao(Beijing Tsinghua Chang Gung Hospital), Kristy L. Richards(University of North Carolina at Chapel Hill), April Chiu(Mayo Clinic), Xiaoxiao Wang(The University of Texas MD Anderson Cancer Center), Youli Zu(Methodist Hospital), Miguel Á. Piris(Hospital Universitario Fundación Jiménez Díaz), Santiago Montes‐Moreno(Universidad de Cantabria), Dennis P. O’Malley(Ambry Genetics (United States)), Ganiraju C. Manyam(The University of Texas MD Anderson Cancer Center), Jooryung Huh(Asan Medical Center), Xin Li(China Medical University), Li Zhang(Chongqing Emergency Medical Center), Yi Xia(The University of Texas MD Anderson Cancer Center), Andrés JM Ferreri, L. Jeffrey Medeiros(Delaware Division of Libraries), William W.L. Choi(Chinese University of Hong Kong), Jane N. Winter(Northwestern University)
Cited by 27
Related Papers
The consensus molecular subtypes of colorectal cancer
|Nature Medicine|2015|5.3k
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data
|Blood|2022|2.8k